Chapters

Transcript

Video

Lipid Management Utilizing PCSK9 Inhibitors

Deepak R. Talreja, M.D., discusses the current advances in lipidology. Here he discusses lipid management that utilizes PCSK9 inhibitors, how these effect cholesterol, how to determine if your patient is a candidate for this type of treatment, and what complications one might expect from this treatment. 


Published

February 16, 2018

Created by

Sentara

Related Presenters

Deepak Talreja, M.D.

Deepak Talreja, M.D.

Sentara Cardiology Specialists

View full profile